Colorectal Cancer Mutation Detection Test & FIT-Positive Triage Test
Help evaluate and triage patients who are asymptomatic but have been screened positive by the fecal immunochemical test (FIT) and patients with clinical symptoms and/or signs of colorectal neoplasia.
Research Service
Introducing ColoScape Plus Test
ColoScape PLUS test provides qualitative, algorithmic determination of colorectal cancer-associated mutations and altered methylation in cell-free DNA and proteins in plasma. Physicians will use this information to better evaluate and treat patients with colorectal cancer. Colorectal cancer patients can have various symptoms including persistent changes in bowel habits, rectal bleeding, cachexia, anemia of chronic disease. This test provides high sensitivity to Advanced Adenomas.
Intended use (1): ColoScape PLUS Test is intended to help evaluate and triage patients who are asymptomatic but have been screened positive by the fecal immunochemical test (FIT)
Intended Use (2): ColoScape PLUS Test is intended to help evaluate and triage patients who have clinical symptoms and/or signs of colorectal neoplasia
The DiaCarta Offerings
SERVICE
ColoScape Plus is available at DiaCarta CLIA as a Lab-Developed-Test (LDT) or a research use test.